Medicinal herbs and manufactured drugs for treatment of COVID-19 and its complications in Aden-Yemen
العناوين الأخرى
أعشاب طبية و أدوية مصنعة لعلاج مرضى كوفيد-19 ومضاعفاته في عدن، اليمن
المؤلف
al-Ashwal, Nashwan Salih Muhammad
المصدر
Journal of Medical and Pharmaceutical Sciences
العدد
المجلد 5، العدد 1 (31 مارس/آذار 2021)، ص ص. 1-28، 28ص.
الناشر
تاريخ النشر
2021-03-31
دولة النشر
فلسطين (قطاع غزة)
عدد الصفحات
28
التخصصات الرئيسية
العلوم الطبية والصيدلة والعلوم الصحية
الملخص EN
Aims: To detect the herbs benefits in treatment of COVID-19 patients.
To discover the effect of coronavirus-2 on the clinical and subclinical diseases that has accompanied with/ or caused by H.
pylori infection or vice versa.
Results: A study of observational clinical trial with randomly selected patients, enrolled to it 775 patients; 35 of them, have suffered of chikungunya and dengue fevers, and the remaining 740 patients were of confirmed and highly suspected COVID-19 cases.
They were divided into six groups; four of them have a manifestations of COVID-19 of confirmed and suspected cases, the 5th group was for patients with other viral causes; chikungunya and dengue fevers, and the sixth was a group of extra-pulmonary manifestations, and each one was subdivided into two subgroups except group D that was subdivided into three subgroups.
The patients that were giving an Echinacea syrup had treated within 48 – 72 hours; clinically and para-clinically, earlier than the patients that were giving a combination of herbs; such as Curcuma, Ginger and Cissus rotundifolia whose had got a recovery after 7 days, while the patients that were giving clarithromycin tabs and Echinacea syrup had recovered earliest, i.e.
after 24 hours, it achieved a highest percentage of success that reached 98%, 100% and 100% respectively, i.e.
the medicinal substances of Echinacea purpura have an antiviral effect on CoV-2, that evidenced by the fast and complete cure of COVID 19 manifestations, if compared with the clinical effect of Remdesivir or hydroxychloroquine.
The combination therapy; Echinacea syrup, Ginkgo biloba tabs and the H.
pylori therapeutic and preventive program, has achieved a successful effect on patients’ illness of severe COVID-19 or those with accelerated or aggravated diseases that accompanied with/caused by H.
pylori infection, in post covid-19 period.
The patients with chikungunya and dengue fevers haven't responded to the Echinacea herbal therapy; i.e.
Echinacea has no benefit in these two diseases but it has an efficient effect against COVID-19.
Conclusion: This study proves the following: I) The medicinal extracts from Echinacea purpurea have an efficient effect against novel-CoV-2 disease, faster than Curcuma, Ginger and Cissus rotundifolia, but the Echinacea and clarithromycin have a fastest remedy from the COVID-19.
II) The combination of Echinacea, H.
pylori therapeutic and preventive program, and Ginkgo biloba, is a successful regime for treating of patients with severe Covid-19, and whose suffered of post covid-19 extra-pulmonary diseases, allowed them to return to their work after 7 days of treatment only "Inshaa Allah".
III) Coronavirus-2 had accelerated the subclinical and aggravated the clinically apparent diseases that has accompanied with /caused by H.
pylori infection.-
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
al-Ashwal, Nashwan Salih Muhammad. 2021. Medicinal herbs and manufactured drugs for treatment of COVID-19 and its complications in Aden-Yemen. Journal of Medical and Pharmaceutical Sciences،Vol. 5, no. 1, pp.1-28.
https://search.emarefa.net/detail/BIM-1316254
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
al-Ashwal, Nashwan Salih Muhammad. Medicinal herbs and manufactured drugs for treatment of COVID-19 and its complications in Aden-Yemen. Journal of Medical and Pharmaceutical Sciences Vol. 5, no. 1 (Mar. 2021), pp.1-28.
https://search.emarefa.net/detail/BIM-1316254
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
al-Ashwal, Nashwan Salih Muhammad. Medicinal herbs and manufactured drugs for treatment of COVID-19 and its complications in Aden-Yemen. Journal of Medical and Pharmaceutical Sciences. 2021. Vol. 5, no. 1, pp.1-28.
https://search.emarefa.net/detail/BIM-1316254
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
رقم السجل
BIM-1316254
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر